Transcriptional profiling demonstrates altered characteristics of CD8 (+) cytotoxic T‐cells and regulatory T‐cells in TP53‐mutated acute myeloid leukemia

BACKGROUND: Acute myeloid leukemia (AML) patients have limited effect from T‐cell‐based therapies, such as PD‐1 and CTLA‐4 blockade. However, recent data indicate that AML patients with TP53 mutation have higher immune infiltration and other immunomodulatory therapies could thus potentially be effec...

Descripción completa

Detalles Bibliográficos
Autores principales: Abolhalaj, Milad, Sincic, Viktor, Lilljebjörn, Henrik, Sandén, Carl, Aab, Alar, Hägerbrand, Karin, Ellmark, Peter, Borrebaeck, Carl A. K., Fioretos, Thoas, Lundberg, Kristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359873/
https://www.ncbi.nlm.nih.gov/pubmed/35297213
http://dx.doi.org/10.1002/cam4.4661

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359873/
https://www.ncbi.nlm.nih.gov/pubmed/35297213
http://dx.doi.org/10.1002/cam4.4661

Ejemplares similares